Levetiracetam monotherapy - Outcomes from an epilepsy clinic

Seizure

Volumn 20, Issue 7, 2011, Pages 554-557

  Stephen, Linda J ^a   Kelly, Kevin ^a   Parker, Pamela ^a   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drug; Epilepsy; Levetiracetam; Monotherapy; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM;

ADOLESCENT; ADULT; AGED; AGGRESSION; ARTICLE; ATAXIA; CHILD; DEPRESSION; DIZZINESS; DRUG DOSE TITRATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPILEPSY; FEMALE; GENERALIZED EPILEPSY; HOSPITAL; HUMAN; IRRITABILITY; LETHARGY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MYOCLONUS EPILEPSY; NAUSEA; NEUROPSYCHIATRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEDATION; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; UNITED KINGDOM; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; RETROSPECTIVE STUDIES; SCOTLAND; TREATMENT OUTCOME;

EID: 79960922913     PISSN: 10591311     EISSN: 15322688     Source Type: Journal    
DOI: 10.1016/j.seizure.2011.04.004     Document Type: Article

References (20)

1. B.A. Lynch, N. Lambeng, K. Nocka, P. Kensel-Hammes, S.M. Bajjalieh, and A. Matagne The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam Proc Natl Acad Sci U S A 101 2004 9861 9866 (Pubitemid 38869327)
2. E. Ben-Menachem, U. Falter for the European Levetiracetam Study Group Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy Epilepsia 41 2000 1276 1283
3. M.J. Brodie, E. Perucca, P. Ryvlin, E. Ben-Menachem, Meencke HJ for the Levetiracetam Monotherapy Study Group Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy Neurology 68 2007 402 408 (Pubitemid 46208740)
4. E. Von Elm, D. Altman, S.J. Pocock, P.C. GØtzsche, J.P. Vandenbroucke for the STROBE Initiative Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Br Med J 335 2007 806 808 (Pubitemid 350057266)
5. M. Zwarenstein, S. Treweek, J.J. Gagnier, D.G. Altman, S. Tunis, and B. Haynes Improving the reporting of pragmatic trials: an extension of the CONSORT statement Br Med J 337 2008 1223 1226
6. P. Kwan, and M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314 319 (Pubitemid 30075244)
7. T.M. Alsaadi, and C. Thieman Levetiracetam monotherapy for newly diagnosed epilepsy patients Seizure 12 2003 154 156 (Pubitemid 36452286)
8. T.M. Alsaadi, A. Shatzel, A. Vinter Marquez, J. Jorgensen, and S. Farias Clinical experience of levetiracetam for adults with epilepsy: 1-year follow-up study Seizure 14 2005 139 142 (Pubitemid 40214742)
9. T.M. Alsaadi, S. Koopmans, M. Apperson, and S. Farias Levetiracetam monotherapy for elderly patients with epilepsy Seizure 13 2004 58 60 (Pubitemid 38139667)
10. V. Belcastro, C. Costa, F. Galletti, F. Pisani, P. Calabresi, and L. Parnetti Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study Eur J Neurol 14 2007 1176 1178 (Pubitemid 47459735)
11. E. Cumbo, and L.D. Ligori Levetiracetam lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease Epilepsy Behav 17 2010 461 466
12. Collaborative Group for the Study of Epilepsy Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy Epilepsia 33 1992 45 51
13. M. Sillanpaä Remission of seizure and predictors of intractability in long-term follow-up Epilepsia 34 1993 930 936 (Pubitemid 23298494)
14. R. Mohanraj, and M.J. Brodie Diagnosing refractory epilepsy: response to sequential treatment schedules Eur J Neurol 13 2006 277 282
15. J. Beavis, A. Meek, D. Felce, and M. Kerr A prospective multicentre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities Seizure 18 2009 279 284
16. K. Kelly, L.J. Stephen, and M.J. Brodie Levetiracetam for people with mental retardation and refractory epilepsy Epilepsy Behav 5 2004 878 883 (Pubitemid 40003909)
17. M. Mula, M.R. Trimble, A. Yuen, R.S. Liu, and J.W. Sander Psychiatric adverse events during levetiracetam therapy Neurology 61 2003 704 706 (Pubitemid 37082613)
18. V. Dinkelacker, T. Dietl, G. Widman, U. Lengler, and C.E. Elger Aggressive behaviour of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases Epilepsy Behav 4 2003 537 547 (Pubitemid 37407612)
19. J.R. White, T.S. Walczak, I.E. Leppik, J. Rarick, T. Tran, and T.E. Beniak Discontinuation of levetiracetam because of behavioral side effects Neurology 61 2003 1218 1221 (Pubitemid 37377540)
20. R. Mohanraj, P. Parker, L.J. Stephen, and M.J. Brodie Levetiracetam in refractory epilepsy: a prospective observational study Seizure 14 2005 23 27 (Pubitemid 40103953)